FACULTY
Evaluating New Developments for the Clinical Management of High Blood Cholesterol
First in a Three Part Series: Proceedings from a Roundtable Symposium
Activity Date: March 2002  — Activity Info: Volume 2, (5)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

PROGRAM CHAIRPERSONS

    Roger S. Blumenthal, MD
    Director of Preventive Cardiology
    The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease
    Johns Hopkins University School of Medicine
    Baltimore, Maryland
    • Dr Blumenthal reports receiving grants and/or research support from Merck, Pfizer, Wyeth-Ayerst, Bristol-Myers Squibb, and Novartis; receiving honoraria from Merck, Pfizer, Medcom, and Physician's World.

    Peter O. Kwiterovich, Jr, MD
    Professor of Medicine and Pediatrics
    Johns Hopkins University School of Medicine
    Director, Johns Hopkins University Lipid Clinic
    Chief, Lipid Research
    Johns Hopkins University Hospital
    Baltimore, Maryland
    • Dr Kwiterovich reports receiving grants and/or research support from AstraZeneca, Merck, Kos, and Pfizer; serving as a consultant and receiving honoraria from Merck, Sankyo Pharma, and Kos.

PARTICIPATING FACULTY

    Sherita Hill Golden, MD, MHS
    Faculty - Endocrinology
    Johns Hopkins University School of Medicine
    Baltimore, Maryland
    • Dr Golden reports receiving grants and/or research support from The Robert Wood Johnson Foundation.

    Howard Knapp, MD, PhD
    Executive Director
    Deaconess Billings Clinic
    Billings, Montana
    • Dr Knapp reports receiving grants and/or research support from Pfizer, Merck, Novartis, Knoll, Amgen, Bayer, Bristol-Myers Squibb, SmithKline Beecham, Pharmacia, Aventis, Wyeth-Ayerst, Schering-Plough, and Sankyo Pharma; receiving honoraria from Roche, Bayer, and Sankyo Pharma.

    William C. Little, MD
    Chief - Cardiology Section
    Wake Forest University Baptist Medical Center
    Winston-Salem, North Carolina
    • Dr Little reports receiving grants and/or research support from Merck; and serving as a consultant for Merck and Sankyo.

    James J. Maciejko, MD, PhD
    Director of Preventive Cardiology
    St. Johns Hospital
    Detroit, Michigan
    • Dr Maciejko reports receiving grants and/or research support from Merck, Pfizer, Beckman-Coulter, and Roche; receiving honoraria from Sankyo Pharma, Pfizer, Merck, Kos, DuPont, and Abbott.

    David G. Robertson, MD
    Assistant Clinical Professor
    Emory University School of Medicine
    Physician - Atlanta Diabetes Association
    Atlanta, Georgia
    • Dr Robertson reports serving as a consultant for Kos, and Abbott; receiving honoraria from Pfizer, Bristol-Myers Squibb, and Sankyo Pharma.

    Dennis L. Sprecher, MD
    Section Head Preventive Cardiology
    The Cleveland Clinic Foundation
    Cleveland, Ohio
    • Dr Sprecher reports no financial or advisory relationships with any corporate organization.

Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?